Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Fairway Medical Technologies Inc.

Facebook Twitter LinkedIn Email Comments
Fairway Medical Technologies Inc. of Houston has received $3.8 million in federal funding to conduct Phase II research on optoacoustic breast and prostate cancer diagnostic methods. The NIH’s National Cancer Institute has awarded the company $2.7 million to develop its laser-ultrasound-nanotechnology system for animal tests and a $1.1 million Small Business Innovation Research grant for the development of a commercial prostate cancer early-detection system. The laser-based technology is used with gold nanorods bound to antibodies to allow higher contrast and definition. It has the potential to detect tumors as small as 2 mm and can differentiate between benign and malignant tumors.

Seno Medical Instruments of San Antonio has purchased Fairway Medical’s optoacoustic technology and will introduce it as a real-time breast cancer detection and diagnosis method. The company will help fund the system’s initial commercialization steps.

BioPhotonics
Dec 2006
BiophotonicsBusinessRapidScan

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.